Eight anticoagulant (AVK) rodenticide active substances had been identified as “Candidates for Substitution”, as part of the Biocidal Products Regulation (BPR, Regulation (EU) 528/2012).
The Official Journal of the European Union has published eight documents regarding regulations and decisions of key pest control products stating that they have now been all been renewed.
What is Biocidal Products Regulation?
BPR concerns biocidal products which are used to protect humans, animals, materials or articles against harmful organisms – such as pests – through the use of active substances contained in the biocides.
All biocidal products require an authorisation to be allowed on the European market, and the all active substances contained within a product must be approved (with a few exceptions for some new active substances).
BPCA lobbying efforts on behalf of members
The European Chemicals Agency (ECHA) ran public consultation concerning the eight key active substances (closing December 2017). BPCA submitted a paper to ECHA and encouraged others to do so including BPCA Manufacturing and Distributors Members.
Simon Forrester, BPCA Chief Executive said:
“We’re very pleased to see that Brussels has seen fit to continue to allow these vital products to be used to protect public health. It is clear the effort BPCA puts into lobbying in Brussels and Westminster is not lost."
Based off these decisions, pest management professionals can be assured that they will continue to have access to these key products.
Links to the Official Journal of the European Union concerning the eight active substances
Document | Concerning | Date | |
2017/1376 |
renewing the approval of warfarin as an active substance |
25 July 2017 |
View |
2017/1377 |
renewing the approval of chlorophacinone as an active substance |
25 July 2017 |
View |
2017/1378 |
renewing the approval of coumatetralyl as an active substance |
25 July 2017 |
View |
2017/1379 |
renewing the approval of difenacoum as an active substance |
25 July 2017 |
View |
2017/1380 |
renewing the approval of bromadiolone as an active substance |
25 July 2017 |
View |
2017/1381 |
renewing the approval of brodifacoum as an active substance |
25 July 2017 |
View |
2017/1382 |
renewing the approval of difethialone as an active substance |
25 July 2017 |
View |
2017/1383 |
renewing the approval of flocoumafen as an active substance |
25 July 2017 |
View |
Scott Johnstone
Content and Communications Officer
30 July 2017 | BPCA Online